AVGO vs NVCT · P/E 87, rev $41.50B vs $304.5M cap
Broadcom Inc (AVGO) versus Nuvectis Pharma Inc (NVCT) — a side-by-side from cached financials, not a winner call.
Broadcom Inc (AVGO) is a semiconductors company listed on US. It is led by Hock Tan.
Nuvectis Pharma Inc (NVCT) is a biotechnology company listed on NASDAQ.
Latest reported AVGO revenue for 2026-05-03 was $41.50B. Net income was $16.66B. AVGO currently screens at market cap $2.12T and trailing P/E 86.9.
NVCT does not have a complete income-statement cache yet.
AVGO currently screens at market cap $2.12T and trailing P/E 86.9. NVCT currently screens at market cap $304.5M.
Not investment advice. Open the AVGO and NVCT stock pages for the full models.
Not investment advice.